Even the Department of Veterans Affairs, where Enge worked, was reluctant to use department resources to patent exendin-4
In one study 22 , inositol supported feelings of anxiety and depression after 12 weeks for women with PCOS compared to Metformin
But what we wanted to understand is what theyre doing in the brain. Key findings GLP-1 drugs act not only on metabolic pathways but also on brain circuits linked to reward Researchers identified a pathway connecting the hindbrain, central amygdala and dopamine-producing neurons The drugs reduce not just hunger, but the desire for high-calorie, rewarding foods Findings may help explain both therapeutic benefits and side effects such as nausea or reduced pleasure Beyond appetite suppression GLP-1 receptor agonists were originally developed to treat Type 2 diabetes by improving insulin response, with weight loss emerging as a secondary benefit
They are deeply rooted in complex, measurable physiological disruptions, including severe mitochondrial dysfunction, rampant oxidative stress, and fundamentally impaired energy metabolism
many notice benefits over 28 weeks